Forestville Healthcare Center | |
7420 Marlboro Pike, Forestville, Maryland 20747 | |
(301) 736-0240 | |
Name | Forestville Healthcare Center |
---|---|
Location | 7420 Marlboro Pike, Forestville, Maryland |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 162 |
Occupancy Rate | 84.32% |
Medicare ID (CCN) | 215020 |
Legal Business Name | Marlboro Leasing Co., Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1003854662 |
Organization Name | MILLENNIUM HEALTH AND REHABILITATION CENTER OF FORESTVILLE LLC |
Doing Business As | FORESTVILLE HEALTH AND REHABILITATION CENTER |
Address | 7420 Marlboro Pike, Forestville, MD 20747 |
Phone Number | 301-736-0240 |
News Archive
Robert Stoler, MD, FACC, FSCAI, director of the Cardiac Catheterization Lab at Baylor Heart and Vascular Hospital and co-medical director, Division of Cardiology, is leading Baylor's participation in an exciting clinical trial to research a new treatment option for AS patients.
Gynesonics, a women's healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its Sonata Sonography-Guided Transcervical Fibroid Ablation (Sonata) System.
A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease.
New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.
› Verified 1 days ago
NPI Number | 1366784282 |
Organization Name | NOVEL INPATIENT SERVICES |
Address | 7420 Marlboro Pike, Forestville, MD 20747 |
Phone Number | 703-879-4500 |
News Archive
Robert Stoler, MD, FACC, FSCAI, director of the Cardiac Catheterization Lab at Baylor Heart and Vascular Hospital and co-medical director, Division of Cardiology, is leading Baylor's participation in an exciting clinical trial to research a new treatment option for AS patients.
Gynesonics, a women's healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its Sonata Sonography-Guided Transcervical Fibroid Ablation (Sonata) System.
A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease.
New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.
› Verified 1 days ago
NPI Number | 1679750897 |
Organization Name | MARLBORO LEASING CO., LLC |
Doing Business As | FORESTVILLE HEALTH & REHABILITATION CENTER |
Address | 7420 Marlboro Pike, Forestville, MD 20747 |
Phone Number | 301-736-0240 |
News Archive
Robert Stoler, MD, FACC, FSCAI, director of the Cardiac Catheterization Lab at Baylor Heart and Vascular Hospital and co-medical director, Division of Cardiology, is leading Baylor's participation in an exciting clinical trial to research a new treatment option for AS patients.
Gynesonics, a women's healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its Sonata Sonography-Guided Transcervical Fibroid Ablation (Sonata) System.
A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease.
New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.
› Verified 1 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Robert Stoler, MD, FACC, FSCAI, director of the Cardiac Catheterization Lab at Baylor Heart and Vascular Hospital and co-medical director, Division of Cardiology, is leading Baylor's participation in an exciting clinical trial to research a new treatment option for AS patients.
Gynesonics, a women's healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its Sonata Sonography-Guided Transcervical Fibroid Ablation (Sonata) System.
A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease.
New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.
› Verified 1 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 23.58 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.11 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 90 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.39 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 24.55 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0.39 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.78 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 1.23 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 82.75 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.88 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 34.25 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 7.36 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 7.03 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.61 | 95.98 |
Percentage of short-stay residents who made improvements in function | 72.76 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 85.71 | 82.93 |
News Archive
Robert Stoler, MD, FACC, FSCAI, director of the Cardiac Catheterization Lab at Baylor Heart and Vascular Hospital and co-medical director, Division of Cardiology, is leading Baylor's participation in an exciting clinical trial to research a new treatment option for AS patients.
Gynesonics, a women's healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its Sonata Sonography-Guided Transcervical Fibroid Ablation (Sonata) System.
A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease.
New research from Boston Medical Center shows that routine Hepatitis C (HCV) testing at federally qualified health centers improves diagnosis rates and health outcomes for people with HCV infections in the United States, and is cost-effective.
› Verified 1 days ago
Forestville Healthcare Center Location: 7420 Marlboro Pike, Forestville, Maryland 20747 Phone: (301) 736-0240 |